EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Adaptive, Stepped‐Care for Cancer‐Related PTSD Symptoms in HCT Survivors: Results From a SMART Trial

Sophia K Smith iD, Eric Kuhn, Tamara J Somers, Eric Laber iD, Cole Manschot iD, Anthony D Sung, Sarah A Kelleher, Catherine Majestic iD, Karen L Syrjala, Deborah Mayer, Sergio Giralt, Andrea Pires und 4 weitere

Psycho-Oncology · 2026

DOI: 10.1002/pon.70554 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Psycho-Oncology, 2026. Verfasst von Sophia K Smith und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Cognitive Behavioral Therapy, Hematopoietic Stem Cell Transplantation, Cancer Survivors. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cancer‐related posttraumatic stress disorder (PTSD) is prevalent among hematopoietic cell transplantation (HCT) survivors, yet access to evidence‐based care is limited. This study evaluated adaptive, stepped‐care treatment sequences for PTSD symptoms using a Sequential Multiple Assignment Randomized Trial (SMART), comparing digital and therapist‐delivered interventions.

Methods

HCT survivors ( N = 477), 1–5 years post‐transplant, with probable or subthreshold PTSD, were randomized to the Cancer Distress Coach (CaDC) app or Usual Care. At Week 4, non‐responders (i.e., < 5‐point PCL‐5 reduction) were re‐randomized to CaDC + Coaching or therapist‐delivered cognitive behavioral therapy for PTSD (CBT‐PTSD). PTSD symptoms (primary outcome), depression, and anxiety were assessed at baseline, Week 4, Month 3 (primary endpoint), and Month 6.

Results

Both initial treatment groups demonstrated symptom reductions at Week 4 with no significant between‐group differences; approximately 60% met early response criteria. By Month 3, outcomes reflected treatment escalation rather than direct comparison of initial interventions. Regimen‐level analyses demonstrated differences across adaptive sequences for PTSD at Months 3 and 6, and for depression and anxiety at Month 3 (global p ‐values ≤ 0.018). Regimens escalating to CBT‐PTSD were associated with greater and more sustained reductions than those escalating to CaDC + Coaching. The sequence initiating with CaDC and escalating to CBT‐PTSD produced the largest effects.

Conclusions

Although a self‐guided digital intervention did not outperform Usual Care initially, adaptive stepped‐care strategies that triage early responders and escalate non‐responders to therapist‐delivered CBT‐PTSD were associated with the greatest reductions in symptoms. Digital tools may function as entry points within stepped‐care models to allocate higher‐intensity psychotherapy. Trials registration ClinicalTrials.gov , NCT04058795, registered 8/16/2019

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stress Disorders, Post-TraumaticCognitive Behavioral TherapyHematopoietic Stem Cell TransplantationCancer SurvivorsNeoplasmsHumansFemaleMaleMiddle AgedAdultDepressionAgedAnxietyMobile ApplicationsTreatment Outcome

Stichwörter der Autor:innen

PCL‐5SMARTadaptive interventioncancer distress coachcancer‐related PTSDdigital CBThematopoietic cell transplantationmobile healthstepped‐caresurvivorship

Autor:innen und Institutionen

  • School of Nursing, Duke University, Durham, North Carolina, USA.
  • Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Dissemination and Training Division, National Center for PTSD, Palo Alto, California, USA.
  • Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, California, USA.
  • Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA.
  • Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.

ORCID-Profile: Sophia K Smith, Eric Laber, Cole Manschot, Catherine Majestic, Rebecca R Gebert, Jean C Yi, Allison J Applebaum

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Smith, S. K., Kuhn, E., Somers, T. J., Laber, E., Manschot, C., Sung, A. D., Kelleher, S. A., Majestic, C., Syrjala, K. L., Mayer, D., Giralt, S., Pires, A., Gebert, R. R., Owen, J. E., Yi, J. C., & Applebaum, A. J. (2026). Adaptive, Stepped‐Care for Cancer‐Related PTSD Symptoms in HCT Survivors: Results From a SMART Trial. Psycho-Oncology. https://doi.org/10.1002/pon.70554

Vancouver

Smith SK, Kuhn E, Somers TJ, Laber E, Manschot C, Sung AD, et al. Adaptive, Stepped‐Care for Cancer‐Related PTSD Symptoms in HCT Survivors: Results From a SMART Trial. Psycho-Oncology. 2026. doi:10.1002/pon.70554

BibTeX
@article{Smith2026,
  author = {Smith, Sophia K and Kuhn, Eric and Somers, Tamara J and Laber, Eric and Manschot, Cole and Sung, Anthony D and Kelleher, Sarah A and Majestic, Catherine and Syrjala, Karen L and Mayer, Deborah and Giralt, Sergio and Pires, Andrea and Gebert, Rebecca R and Owen, Jason E and Yi, Jean C and Applebaum, Allison J},
  title = {Adaptive, Stepped‐Care for Cancer‐Related PTSD Symptoms in HCT Survivors: Results From a SMART Trial},
  journal = {Psycho-Oncology},
  year = {2026},
  doi = {10.1002/pon.70554}
}
Kostenlos starten →